The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.
| Day 1 – September 5, 2026 | ||||
|---|---|---|---|---|
Welcome and Opening Session |
17:00 – 17:10 | Opening Address from the ISN Leadership | ISN Representative | TBC |
| 17:10 – 17:20 | CSN Representative’s Welcome Address | Guangyan Cai | China | |
| 17:20 – 17:30 | Welcome and Opening Remarks by ISN Frontiers Co-chairs | Masaomi Nangaku / Sola Aoun Bahous | Japan / Lebanon | |
| 17:30 – 18:30 | Why Kidney Registries Matter | Sola Aoun Bahous Fergus Caskey |
Lebanon United Kingdom |
|
| Welcome & Networking Reception | 18:30 – 19:30 | Welcome & Networking Reception (60 minutes) | ||
| Day 2 – September 6, 2026 | ||||
|---|---|---|---|---|
| Session 2: Keynote | 08:30 – 09:10 | MRAs for Cardio-Kidney-Metabolic Health | Peter Stevinkel | Sweden |
Session 3:Cardio-kidney-metabolic 1 – Research and clinical trials Integrating CKM Research and Clinical Trials Into Patient Care |
09:15 – 09:40 | Linking MRA to Cardio-Kidney-Metabolic Care | Katherine Tuttle | USA |
| 09:40 – 10:05 | Intensive Blood Pressure Control for Better Outcomes in Diabetic CKD | Yu-Fang Bi | China | |
| Coffee Break | 10:05 – 10:30 | Coffee Break and Poster Viewing (25 minutes) | ||
Session 4:Rare Kidney Diseases 1 – Implementation Rare Kidney Diseases: From Mechanisms to Implementation |
10:30 – 10:55 | Endothelin A Receptor Antagonists in IgA Nephropathy | Meg Jardine | Australia |
| 10:55 – 11:20 | How Complement Pathways Drive IgA Nephropathy | Sung Gyun Kim | South Korea | |
| 11:20 – 11:45 | CRISPR Gene Editing for APOL1-Associated Kidney Disease | Sydney Tang | Hong Kong (China) | |
| Lunch Break | 11:45 – 13:15 | Lunch Break / Lunch Symposium (90 minutes) | ||
Session 5:AKI Innovations in AKI: From Lab to Clinic |
13:15 – 13:40 | Linking Molecular Pathways to AKI Outcomes | Motoko Yanagita | Japan |
| 13:40 – 14:05 | Can AI Detect AKI Early? | Sejoong Kim | South Korea | |
| 14:05 – 14:30 | Protecting Kidneys in Cardiac Surgery: The RIPC Approach | Xiao-Qiang Ding | China | |
| 14:30 – 14:55 | Stem Cell Therapy for AKI: From Bench to Bedside | Guangyan Cai | China | |
| Coffee Break | 14:55 – 15:25 | Coffee Break and Poster Viewing (30 minutes) | ||
Session 6:Cardio-kidney-metabolic 2 – Implementation Implementing Cardio-Kidney-Metabolic Care: From Mechanisms to Global Burden |
15:25 – 15:50 | Molecular Mechanisms of Cardio-Kidney-Metabolic Syndrome | Jin Joo Cha | South Korea |
| 15:50 – 16:15 | Burden of Cardio-Kidney-Metabolic Syndrome in Asia | Sunita Bavanandan | Malaysia | |
| 16:15 – 16:40 | Cardio-Kidney-Metabolic Syndrome: An Integrated Approach to the Global Health Burden | Pringgodigdo Nugroho | Indonesia | |
| 16:40 – 17:05 | TBC | Magdalena Madero | Mexico | |
| Industry Symposium | 17:05 – 18:05 | Industry Symposium (60 minutes) | ||
| Day 3 – September 7, 2026 | ||||
|---|---|---|---|---|
Session 7: Keynote |
08:30 – 09:10 | Telemedicine and AI for Smarter Nephrology Practice | Masaomi Nangaku | Japan |
Session 8:Innovations & AI in Nephrology – Panel |
09:15 – 10:15 | AI in Transplantation Pathology | Alton B Farris | USA |
| Unveiling Kidney Disease Through Body Gas Sensing Techniques | Yosuke Hirakawa | Japan | ||
| Multi-Stain Deep Learning Model to Predict Treatment Response in Lupus Nephritis | Wei Chen | China | ||
| AI and Kidney Disease | Lu-Xia Zhang | China | ||
| Coffee Break | 10:15 – 10:45 | Coffee Break and Poster Viewing (30 minutes) | ||
Session 9:Blood Purification |
10:45 – 11:10 | Glycation End Products and Kidney Disease | Kornchanok Vareesangthip | Thailand |
| 11:10 – 11:35 | Peritoneal Dialysis: Advances and Challenges | Winston Fung | Hong Kong (China) | |
| 11:35 – 12:00 | HIF Inhibitors: Transforming Anaemia Care | Ping Li | China | |
| 12:00 – 12:25 | Novel Blood Purification Approaches in Kidney Care | Hong-Li Lin | China | |
| 12:25 – 12:40 | Oral Presentation from abstract submission | Abstract | ||
| Lunch Break | 12:40 – 14:10 | Lunch Break / Lunch Symposium (90 minutes) | ||
Session 10:Rare Kidney Diseases – Research and Clinical Trials |
14:10 – 14:35 | Genetic Diagnosis of Rare Kidney Diseases | Krzysztof Kiryluk | USA |
| 14:35 – 15:00 | Rare Kidney Diseases in China: Challenges and Progress | Li-Meng Chen | China | |
| 15:00 – 15:25 | Managing Kidney Involvement in Lupus | Liz Lightstone | UK | |
| 15:25 – 15:50 | Improving Outcomes for Children With Rare Kidney Disease | Franz Schaefer | Germany | |
| 15:50 – 16:05 | Oral Presentation from abstract submission | Abstract | TBC | |
| Coffee Break | 16:05 – 16:35 | Coffee Break and Poster Viewing (30 minutes) | ||
Session 11:Cardio-kidney-metabolic 3 & Closing Remarks |
16:35 – 17:00 | Integrating GLP-1RA Into Cardio-Kidney-Metabolic Management | Vlado Perkovic | Australia |
| 17:00 – 17:25 | SGLT2i for CKD: Expanding Benefits Beyond Diabetes | Xiao-Xi Zeng | China | |
| 17:25 – 17:40 | Oral Presentation from abstract submission | Abstract | TBC | |
| 17:40 – 18:00 | Reflections and Closing Remarks From the ISN Frontiers Co-chairs | Guangyan Cai, Masaomi Nangaku, Sola Aoun Bahous | China / Japan / Lebanon | |